Carvedilol may attenuate liver cirrhosis by inhibiting angiogenesis through the VEGF-Src-ERK signaling pathway

Figure 3 Effect of carvedilol on cell migration. A: HUVECs were scraped and then treated with or without VEGF (50 ng/mL) and various concentrations of carvedilol. Images were taken at 0 and 24 h after scraping; B: Cell migration across the scraped area was determined using ImageJ software. (n = 12, ^aP < 0.05 vs control, ^bP < 0.01 vs VEGF alone). HUVEC: Human umbilical vascular endothelial cell; VEGF: Vascular endothelial growth factor.